Each year, 400,000 children around the world develop cancers such as leukemia and lymphoma.
The UK’s Great Ormond Street Hospital (GOSH) children’s charity and the US Oliver Patch Project have joined forces with Innovative Trials to form two strategic partnerships to accelerate childhood cancer research.
Innovative Trials has been working with the Oliver Patch Project and the GOSH charity since last year.
Leukaemia and lymphoma are two of the most common childhood cancers, affecting more than 6,000 children each year in the UK and US, and around 400,000 children worldwide.
In the UK, Innovative Trials is fundraising for GOSH Charity’s Build it. Beat it. Appeal, which aims to raise £300 million to support the building of GOSH’s new Children’s Cancer Centre, which aims to increase research capacity and drive transformational change in childhood cancer care.
In the US, Innovative Trials has committed to donating $6 to the Oliver Patch Project every time a child or teen enrols in a paediatric clinical trial sponsored by Innovative Trials’ Retention Patch Programme, and raises funds for the US non-profit organisation through industry events and internal fundraising efforts.
As part of its Patches of Positivity program, the Oliver Patch Project provides children in the organization’s programs with colorful, collectible patches with distinctive designs, along with collectible cards, animations and coloring books each month for the duration of their treatment.
